While antibiotics are standard for CE, immunosuppressive strategies (e.g., corticosteroids, tacrolimus) and immunostimulatory agents (e.g., G-CSF) are being explored for NK-related dysfunction. The gene discussed is CSF3; the disease is cholesteryl ester measurement.